Jim Cramer: Don't Buy This Health Care Stock Yet, It Is 'Still Too Expensive'
1. Doximity's earnings beat estimates but shares declined 3.3%. 2. IREN's earnings significantly surpassed expectations, but shares fell 2.9%. 3. Boise Cascade missed earnings estimates, yet shares rose 0.9%. 4. Cramer advises selling IREN and waiting on Doximity investments. 5. Cramer stresses need for Fed rate cuts to improve housing stocks.